Treatment Options in Patients Suffering from Hemolytic-Uremic Syndrome: The Serbian Military Medical Academy Experience Cover

.blurhash-client-img { display: none !important; }

Treatment Options in Patients Suffering from Hemolytic-Uremic Syndrome: The Serbian Military Medical Academy Experience

EABR. Experimental and Applied Biomedical Research

Volume 23 (2022): Issue 3 (September 2022)

By: Jelena Tadic, Mirjana Mijuskovic, Marijana Petrovic, Katarina Obrencevic, Brankica Terzic, Violeta Rabrenovic, Neven Vavic and Đoko Maksic

Open Access

|Sep 2022

Authors

Jelena Tadic

j.tadic2010@gmail.com

Military Medical Academy, Clinic for Nephrology, Belgrade, Serbia

Mirjana Mijuskovic

Military Medical Academy, Clinic for Nephrology, Belgrade, Serbia

Marijana Petrovic

Military Medical Academy, Clinic for Nephrology, Belgrade, Serbia

Katarina Obrencevic

Military Medical Academy, Clinic for Nephrology, Belgrade, Serbia

Brankica Terzic

Military Medical Academy, Clinic for Nephrology, Belgrade, Serbia

Violeta Rabrenovic

Military Medical Academy, Clinic for Nephrology, Belgrade, Serbia

Neven Vavic

Military Medical Academy, Clinic for Nephrology, Belgrade, Serbia

Đoko Maksic

Military Medical Academy, Clinic for Nephrology, Belgrade, Serbia

DOI: https://doi.org/10.2478/sjecr-2019-0060 | Journal eISSN: 2956-2090 | Journal ISSN: 2956-0454

Journal RSS Feed

Language: English

Page range: 237 - 242

Submitted on: Jun 27, 2019

Accepted on: Sep 16, 2019

Published on: Sep 20, 2022

Published by: University of Kragujevac, Faculty of Medical Sciences

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

Hemolytic-uremic syndrome,

atypical hemolytic-uremic syndrome,

C3,

corticosteroids,

Related subjects:

Clinical medicine,

Clinical medicine, other

© 2022 Jelena Tadic, Mirjana Mijuskovic, Marijana Petrovic, Katarina Obrencevic, Brankica Terzic, Violeta Rabrenovic, Neven Vavic, Đoko Maksic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 23 (2022): Issue 3 (September 2022)Next article